Cargando…
Anti-IgE: A treatment option in allergic rhinitis?
Background: Allergic rhinitis (AR) is the most common IgE-mediated allergic disease. Multiple clinical trials have demonstrated promising results on the AR treatment with biologics, in particular with the use of omalizumab – an anti-IgE antibody. Omalizumab has also been established in the routine m...
Autores principales: | Pfaar, Oliver, Gehrt, Francesca, Li, Hansen, Rudhart, Stefan A., Nastev, Alexander, Stuck, Boris A., Hoch, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905705/ https://www.ncbi.nlm.nih.gov/pubmed/33644635 http://dx.doi.org/10.5414/ALX02205E |
Ejemplares similares
-
Nasal IgE in subjects with allergic and non-allergic rhinitis
por: Eckrich, Jonas, et al.
Publicado: (2020) -
Local IgE in patients with allergic rhinitis
por: Rodrigues, Adriana Teixeira, et al.
Publicado: (2015) -
Analysis of bacterial contamination and the effectiveness of UV light-based reprocessing of everyday medical devices
por: Rudhart, Stefan Alexander, et al.
Publicado: (2022) -
UV light-based decontamination: an effective and fast way for disinfection of endoscopes in otorhinolaryngology?
por: Rudhart, Stefan A., et al.
Publicado: (2020) -
The Prevalence of Serum Specific IgE to Superantigens in Asthma and Allergic Rhinitis Patients
por: Liu, Jing Nan, et al.
Publicado: (2014)